ChartRow logo
Share this page
NVAX
$11.26-12.17%
as of close, Oct 16, 2026
☾ AH $11.26 -12.17%
PeersMRNALLYMDTUNHJNJTMO

NVAX — Novavax Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in NVAX be worth today? →
NVAX returns: By year · By month · By week · Trailing

Key stats#

Price data

Price
$11.26
YTD price return
+67.56%
YTD total return
+67.56%
Next earnings
Nov 5, 2026
Market cap
1.9B
Enterprise value
1.5B
Shares outstanding
164.9M
52W low
$6.20
52W high
$13.39
From 52W high
-15.91%
From 52W low
+81.61%
52W range
70%

Volume

Rel volume
1.30×
30D volume
7.6M
30D $ vol
85.6M

Fundamentals

Sales (ttm)
413.8M
Sales/share
$2.51
EPS (ttm)
-$1.46
FCF (ttm)
-42.2M
FCF/share
-$0.26
Book value/share
-$1.16
Net margin
-59.87%
ROA
-25.92%
Current ratio
2.33

Growth (CAGR, ttm) · 10Y

Sales
-61.67%-36.25%-18.94%+36.02%
Shares
+1.56%+20.44%+17.24%+28.39%

Per-share growth (CAGR, ttm) · 10Y

Sales/share
-62.25%-47.07%-30.85%+5.94%
Price
+32.81%+19.30%-41.32%-9.69%
Total return
+32.81%+19.30%-41.32%-9.69%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
-7.7×
Fwd P/E
-77.8×
P/S (ttm)
4.5×
P/B (mrq)
-9.7×
EV/EBITDA (fy)
3.0×
EV/Sales (ttm)
3.5×
FCF yield (ttm)
-2.27%
Buyback yield (realized, 1y)
-1.56%
Shareholder yield (realized, 1y)
-1.56%
Buyback yield (cash, ttm)
0.00%
Shareholder yield (cash, ttm)
0.00%

Vs own 10Y history

P/S
45th

Bar = where today’s multiple sits in NVAX’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

1D
-12.17%
5D
-11.69%
1M
+20.43%
3M
+36.65%
YTD
+67.56%
1Y
+32.78%
5Y
-93.05%

Financial statements

Open full NVAX financials →
Loading financial statements…
TickerName1M1D
LLYEli Lilly and Company+10.48%+0.43%
JNJJohnson & Johnson-4.38%+0.90%
ABBVAbbVie Inc.+8.73%+0.71%
UNHUnitedHealth Group Incorporated Common Stock (DE)+6.97%-1.29%
MRKMerck & Co. Inc.+0.72%+0.52%
NVSNovartis AG+8.59%+0.16%
TMOThermo Fisher Scientific Inc.+6.41%-0.93%
AMGNAmgen Inc.+14.92%-0.35%